Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Wendy G Mitchell, MD

    TitleProfessor of Clinical Neurology and Pediatrics
    SchoolKeck School of Medicine of USC
    DepartmentPediatrics
    AddressCHL Mail Stop 82
    Off Campus
    Los Angeles California 90089
    Phone+1 323 361 2471
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Wendy Mitchell, MD, is Professor of Clinical Neurology, Keck School of Medicine, University of Southern California. She is acting Division Head of Neurology at Childrens Hospital Los Angeles, where she has practiced for over 30 years. She is a native of Los Angeles. Her current research interests include cognitive and behavioral aspects of childhood epilepsy, clinical research in anticonvulsants, and a rare immune-mediated syndrome, opsoclonus-myoclonus (or dancing eyes syndrome). In her free time she enjoys scuba diving and yoga.


      Collapse ORNG Applications 
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Fu X, Francisco C, Pattengale P, O'Gorman MR, Mitchell W. An Adolescent with Increased Plasma Methylmalonic Acid and Total Homocysteine. Clin Chem. 2017 Jun; 63(6):1069-1072. PMID: 28550124.
        View in: PubMed
      2. Sirois PA, Aaron L, Montepiedra G, Pearson DA, Kapetanovic S, Williams PL, Garvie PA, Nozyce ML, Malee K, Nichols SL, Kammerer BL, Mitchell W, Mintz M, Oleske JM. Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV. Pediatr Infect Dis J. 2016 Jan; 35(1):e12-8. PMID: 26741589; PMCID: PMC4705843 [Available on 01/01/17].
      3. Desai J, Ramos-Platt L, Mitchell W. Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions. Ann Indian Acad Neurol. 2015 Jul-Sep; 18(3):327-30. PMID: 26425012; PMCID: PMC4564469.
      4. Ng YT, Conry J, Mitchell W, Buchhalter J, Isojarvi J, Lee D, Drummond R, Chung S. Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term clinical trial results. Epilepsy Behav. 2015 May; 46:221-6. PMID: 25940107.
        View in: PubMed
      5. Wirrell EC, Shellhaas RA, Joshi C, Keator C, Kumar S, Mitchell W. How should children with West syndrome be efficiently and accurately investigated? Results from the National Infantile Spasms Consortium. Epilepsia. 2015 Apr; 56(4):617-25. PMID: 25779538.
        View in: PubMed
      6. Mitchell W, Wooten AA, O'Neil SH, Rodriguez JG, Cruz RE, Wittern R. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS). J Child Neurol. 2015 Jul; 30(8):976-82. PMID: 25342308.
        View in: PubMed
      7. Conry JA, Ng YT, Kernitsky L, Mitchell W, Veidemanis R, Drummond R, Isojarvi J, Lee D, Paolicchi JM. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years. Epilepsia. 2014 Apr; 55(4):558-67. PMID: 24580023; PMCID: PMC4303987.
      8. Desai J, Mitchell W. Assessment of control in typical childhood absence epilepsy. J Child Neurol. 2013 May; 28(5):678-9. PMID: 23529908.
        View in: PubMed
      9. Desai J, Mitchell W. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome. J Child Neurol. 2012 Nov; 27(11):1482-8. PMID: 22805251.
        View in: PubMed
      10. Tate ED, Pranzatelli MR, Verhulst SJ, Markwell SJ, Franz DN, Graf WD, Joseph SA, Khakoo YN, Lo WD, Mitchell W, Sivaswamy L. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol. 2012 Jul; 27(7):875-84. PMID: 22378659.
        View in: PubMed
      11. Desai J, Mitchell W, Rosser T, Ramos-Platt L, Ahsan N, Langille MM, Toczek MT. Clinical associations of occipital intermittent rhythmic delta activity. J Child Neurol. 2012 Apr; 27(4):503-6. PMID: 21940699.
        View in: PubMed
      12. Desai JD, Toczek MT, Mitchell W. Frontal intermittent rhythmic delta activity (FIRDA): is there a clinical significance in children and adolescents? Eur J Paediatr Neurol. 2012 Mar; 16(2):138-41. PMID: 21775176.
        View in: PubMed
      13. Desai J, Mitchell W. Does one more medication help? Effect of adding another anticonvulsant in childhood epilepsy. J Child Neurol. 2011 Mar; 26(3):329-33. PMID: 21183723.
        View in: PubMed
      14. Crain MJ, Chernoff MC, Oleske JM, Brogly SB, Malee KM, Borum PR, Meyer WA, Mitchell W, Moye JH, Ford-Chatterton HM, Van Dyke RB, Seage Iii GR. Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. J Infect Dis. 2010 Jul 15; 202(2):291-301. PMID: 20533872; PMCID: PMC2913975.
      15. Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell W, Oleske JM. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV. J Dev Behav Pediatr. 2009 Oct; 30(5):403-12. PMID: 19827220; PMCID: PMC2836888.
      16. Partikian A, Mitchell W. Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms. J Child Neurol. 2010 Apr; 25(4):423-8. PMID: 19749181.
        View in: PubMed
      17. Khanlou N, Mathern GW, Mitchell W, Salamon N, Pope WB, Yong WH, Vinters HV. Cortical dysplasia with prominent Rosenthal fiber formation in a case of intractable pediatric epilepsy. Hum Pathol. 2009 Aug; 40(8):1200-4. PMID: 19427021.
        View in: PubMed
      18. Pranzatelli MR, Tate ED, Travelstead AL, Baumgardner CA, Gowda NV, Halthore SN, Kerstan P, Kossak BD, Mitchell W, Taub JW. Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil. J Child Neurol. 2009 Mar; 24(3):316-22. PMID: 19258290.
        View in: PubMed
      19. Conry JA, Ng YT, Paolicchi JM, Kernitsky L, Mitchell W, Ritter FJ, Collins SD, Tracy K, Kormany WN, Abdulnabi R, Riley B, Stolle J. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia. 2009 May; 50(5):1158-66. PMID: 19170737.
        View in: PubMed
      20. Mitchell W, Tseng-Ong L. Reviews of infant botulism at childrens hospital los angeles. J Child Neurol. 2008 Aug; 23(8):968. PMID: 18660481.
        View in: PubMed
      21. Tseng-Ong L, Mitchell W. Infant botulism: 20 years' experience at a single institution. J Child Neurol. 2007 Dec; 22(12):1333-7. PMID: 18174547.
        View in: PubMed
      22. Partikian A, Mitchell W. Major adverse events associated with treatment of infantile spasms. J Child Neurol. 2007 Dec; 22(12):1360-6. PMID: 18174552.
        View in: PubMed
      23. Partikian A, Mitchell W. Iatrogenic botulism in a child with spastic quadriparesis. J Child Neurol. 2007 Oct; 22(10):1235-7. PMID: 17940253.
        View in: PubMed
      24. Glauser TA, Mitchell W, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia. 2007 Jun; 48(6):1117-22. PMID: 17442002.
        View in: PubMed
      25. Turkel SB, Brumm VL, Mitchell W, Tavare CJ. Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia. J Neuropsychiatry Clin Neurosci. 2006; 18(2):239-41. PMID: 16720803.
        View in: PubMed
      26. Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell W, Pike M, Pistoia V. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett. 2005 Oct 18; 228(1-2):275-82. PMID: 15922508.
        View in: PubMed
      27. Mitchell W, Brumm VL, Azen CG, Patterson KE, Aller SK, Rodriguez J. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia. Pediatrics. 2005 Oct; 116(4):901-7. PMID: 16199699.
        View in: PubMed
      28. Mitchell W, Tseng-Ong L. Catastrophic presentation of infant botulism may obscure or delay diagnosis. Pediatrics. 2005 Sep; 116(3):e436-8. PMID: 16140690.
        View in: PubMed
      29. Mitchell W, Shah NS. Vigabatrin for infantile spasms. Pediatr Neurol. 2002 Sep; 27(3):161-4. PMID: 12393124.
        View in: PubMed
      30. Shah NS, Mitchell W, Boles RG. Mitochondrial disorders: a potentially under-recognized etiology of infantile spasms. J Child Neurol. 2002 May; 17(5):369-72. PMID: 12150585.
        View in: PubMed
      31. Mitchell W, Davalos-Gonzalez Y, Brumm VL, Aller SK, Burger E, Turkel SB, Borchert MS, Hollar S, Padilla S. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics. 2002 Jan; 109(1):86-98. PMID: 11773546.
        View in: PubMed
      32. Mitchell W. Status epilepticus and acute serial seizures in children. J Child Neurol. 2002 Jan; 17 Suppl 1:S36-43. PMID: 11918461.
        View in: PubMed
      33. Mitchell W. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev. 2001; 7(3):211-6. PMID: 11553937.
        View in: PubMed
      34. Mitchell W, Scheier LM, Baker SA. Adherence to treatment in children with epilepsy: who follows "doctor's orders"? Epilepsia. 2000 Dec; 41(12):1616-25. PMID: 11114221.
        View in: PubMed
      35. Mitchell W, Conry JA, Crumrine PK, Kriel RL, Cereghino JJ, Groves L, Rosenfeld WE. An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance. North American Diastat Group. Epilepsia. 1999 Nov; 40(11):1610-7. PMID: 10565590.
        View in: PubMed